期刊文献+

基质金属蛋白酶-2,-9在子宫腺肌病的表达 被引量:3

EXPRESSION OF MATRIX METALLOPROTEINASE-2,-9 IN PATIENTS WITH ADENOMYOSIS
暂未订购
导出
摘要 目的 探讨基质金属蛋白酶 2 , 9(MMP 2 , 9)在子宫腺肌病的表达及与发病机制的关系。方法 采用免疫组织化学SP法对 2 8例子宫腺肌病 (疾病组 )异位及原位内膜 ,35例子宫肌瘤 (对照组 )原位内膜中MMP 2 , 9的表达进行测定 ,应用图像分析系统分析MMP 2 , 9平均光密度值。结果 MMP 2 , 9于两组原位内膜中表达均呈月经周期依赖性 ,分泌期的表达强度高于增生期 (P <0 0 5 ) ;于疾病组异位内膜中表达无周期性显著差异 (P >0 0 5 )。疾病组内增生期异位内膜MMP 2 , 9的表达强度高于原位内膜 (P <0 0 5 )。疾病组整个月经周期中 ,MMP 2 , 9于原位及异位内膜的表达皆持续明显高于对照组 (P <0 0 5 )。结论 研究显示子宫腺肌病原位和异位内膜MMP 2 , Objective To investigate the expression of MMP 2, 9 in adenomyosis and its relation with the pathogenesis MethodEndometrium specimens were obtained from 35 patients with hysteromyoma (controls) and 28 with adenomyosis. MMP 2, 9 were detected by immunohistochemical SP staining A computerized image analysis system was used to analyse the expression of MMP 2, 9 ResultThe expression of MMP 2, 9 showed phase dependent changes in the eutopic endometrium of both groups, higher in the secretory phase than in the proliferative phase ( P <0 05) In the ectopic endometrium with adenomyosis, the expression was similar in both phases ( P >0 05), but significantly higher than that in the eutopic endometrium with adenomyosis in the proliferative phase( P <0 05) The expression of MMP 2, 9 in the ectopic and eutopic endometrium with adenomyosis was persistently stronger than that of the controls throughout the menstrual cycle( P <0 05) ConclusionOverexpression of MMP 2, 9 in the ectopic and eutopic endometrium with adenomyosis may be related with the pathologic mechanism ofadenomyosis
出处 《中国组织化学与细胞化学杂志》 CAS CSCD 2002年第3期310-313,共4页 Chinese Journal of Histochemistry and Cytochemistry
关键词 子宫内膜 免疫组织化学 基质金属蛋白酶-2 子宫腺肌病 表达 NMP-9 Matrix metalloproteinase Endometrium Adenomyosis Immunohistochemistry Human
  • 相关文献

参考文献10

  • 1Matrisian LM. Metalloproteinases and their inhibitors in matrix remodeling. Trends Genet 1990,6:121-125
  • 2Fata JE, Ho AT, Leco KJ,et al. Cellular turnover and extracellular matrix remodeling in female reproductive tissues: functions of metalloproteinases and their inhibitors. Cell Mol Life Sci, 2000,57(1):77-95
  • 3Salamonsen LA, Butt AR, Hammond FR, et al .Production of endometrial matrix metalloproteinases, but not their tissue inhibitors, is modulated by progesterone withdrawal in an in vitro model for menstruation.J Clin Endocrinol Metab. 1997,82(5):1409-1415
  • 4Marbaix E,Korkorine I,Moulin P,et al. Menstrual breakdown on human endometrium can be mimicked in vitro and is selectively and reversibly blocked by inhibitors of matrix metalloproteinases. Proc Natl Acad Sci USA, 1996,3:9120-9125
  • 5Wenzl R, Heinzl H.Localization of matrix metalloproteinase-2 in uterine endometrium and ectopic implants. Gynecol Obstet Invest,1998,5:253-257
  • 6Schindl M, Birner P, Obermair A, et al. Increased microvessel density in adenomyosis uteri. Fertil Steril,2001,75:131-135
  • 7Abulafia O, Sherer DM. Angiogenesis of the endometrium. Obstet Gynecol,1999,94:148-153
  • 8Nisolle M, Casanas-Roux F, Marbaix E,et al. Transplantation of cultured explants of human endometrium into nude mice. Hum Reprod, 2000,15:572-577
  • 9袁耀萼主译.临床妇科病理学.北京:人民卫生出版社,1998,第一版:237-238
  • 10濮德敏,杨丹,张萍.基质金属蛋白酶及其抑制剂mRNA在正常及异位子宫内膜中的表达[J].中国组织化学与细胞化学杂志,2002,11(1):47-50. 被引量:1

二级参考文献6

  • 1Chambers AF, Matrisian LM. Changing view of the role of matrix metalloproteinases in metastasis. J Natl Cancer Inst, 1997;89:1260-1270
  • 2Watanabe H, kanzaki H, Narukawa S, et al. Bcl-2 and Fas expression in eutopic and ectopic human endometrium during the menstrual cycle in relation to endometrial cell apoptosis. Am J Obstet Gynecol, 1997;176:360-368
  • 3De-Clerk YA, Darville MI, Eeckhout Y, et al. Characterization of the promoter of the gene encoding human tissue inhibitor of metalloproteinases-2(TIMP-2). Gene, 1994;139(2):185
  • 4Gottschalk C, Malberg K, Aradt M, et al. Matrix metalloproteinases and TACE play a role in the pathogenesis of endometriosis. Adv Exp Med Biol, 2000;477:483-486
  • 5Wenzl RJ, Heinzl H. Localization of matrix me- talloproteinase-2 in endometrium and ectopic implants. Gynecol Obstet Invest, 1998;45(4):253-257
  • 6Sharpe-Timms KL, Keisler LW, Mclntush EW, et al. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of woman with endometriosis and restored in sera by gonadotropin- releasing hormone agonist therapy. Fertile Steril, 1998;69(6):1128-1132

同被引文献43

引证文献3

二级引证文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部